Angusta 25 ug, Tabletten
7680675800018
CH-67580
Tabletten
Associated product:
ANGUSTA cpr 25 mcg 8 pce
1 / 3
google
Article details
- Package size
- 8
- Selling units
- 8
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
misoprostolum
|
0.025 MG | Substance | Wirkstoff (Principe actif) |
|
hypromellosum
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
maydis amylum
|
- | Substance | HNIDK |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
natrium
|
0.87 MG | Substance | HBESI |
|
crospovidonum
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
Authorization holder
Norgine AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 67580
- Drug name
- Angusta, Tabletten
- Galenic form
- TAB
- ATC Code
- G02AD06
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 10/01/2022
- Authorization expiration date
- 31/12/9999
- IT Number
- 09.01.1.
- Domain
- Human medicine
Package details
- Description (FR)
- ANGUSTA cpr 25 mcg 8 pce
- Description (DE)
- ANGUSTA Tabl 25 mcg 8 Stk
- Market launch
- 10/01/2022
- Narcotic (BTM)
- No